Protocol No.: EA2165

Title
A Randomized Phase II Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Principal Investigator
Pahuja, Shalu
Phase
II
Age Group
Adult
Applicable Disease Site
Gastrointestinal Cancers
Participating Institution
Mary Babb Randolph Cancer Center
Contact
Lan Hu, BSN, MPH
Research Nurse
Phone: +1 304-293-6960

View on ClinicalTrials.gov